Park Ha Biological Technology Announces 1-for-50 Reverse Stock Split to Maintain Nasdaq Listing

summarizeSummary

Park Ha Biological Technology announced a 1-for-50 reverse stock split, effective February 20, 2026, a common move for micro-cap companies to meet exchange listing requirements.

check_boxKey Events

• Reverse Stock Split Announced

  The company will implement a 1-for-50 reverse stock split, effective February 20, 2026, with trading on a split-adjusted basis beginning the same day.

• Corporate Approvals

  The reverse split was approved by shareholders on December 26, 2025, and subsequently by the Board of Directors on January 29, 2026.

• Charter Amendment Filed

  An Amended and Restated Memorandum of Association was filed on February 4, 2026, to reduce the authorized share capital and adjust the par value of shares in connection with the split.

auto_awesomeAnalysis

Park Ha Biological Technology Co., Ltd. announced a 1-for-50 reverse stock split, effective February 20, 2026. This action is typically undertaken by micro-cap companies with very low share prices to meet minimum bid price requirements for continued listing on exchanges like Nasdaq. While a reverse split does not change the company's fundamental value, it often signals financial distress and can be viewed negatively by investors, potentially leading to further price erosion post-split. The move follows shareholder approval in December 2025 and board approval in January 2026, and an amended corporate charter was filed to facilitate the change.